QUARTERLY INSIGHTS

March 2022

CASE STUDY: Malignant Peripheral Nerve Sheath Tumor

The Caris Molecular Tumor Board (CMTB) works one-on-one with oncologists to interpret molecular findings and provide therapeutic guidance on difficult-to-treat cases. Read how the CMTB approached a patient with NF1 syndrome and a malignant peripheral nerve sheath tumor. To view or download the case study please click here or on either of the corresponding pages below.